Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy

NCT00822211 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

404

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Vildagliptin 50 mg bid
DRUG: Vildagliptin 50 mg qd
DRUG: Placebo

Sponsor

Novartis